Interleukin-2 and Sargramostim After Chemotherapy in Treating Patients With Stage III or Stage IV Melanoma

Clinical trial NCT00085579 · WITHDRAWN

Trial details

NCT number: NCT00085579
Sponsor: Memorial Sloan Kettering Cancer Center
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 2004-03-01
Primary completion: 2005-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.